Immune signatures underlying post-acute COVID-19 lung sequelae is a research paper published in Science Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 187 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NINDS NIH HHS
Grant: R01 NS103212
NINDS NIH HHS
Grant: RF1 NS122174
NIAID NIH HHS
Grant: U01 AI131566
NIA NIH HHS
Grant: R01 AG069264
NIAID NIH HHS
Grant: R01 AI147394
NIA NIH HHS
Grant: R01 AG047156
NIAID NIH HHS
Grant: R01 AI057459
National Institutes of Health
Grant: 1R13AG013039-01
1995 SUMMER INSTITUTE IN GERIATRIC MEDICINE
National Institutes of Health
Grant: 1R01AG047156-01A1
Simultaneously boosting both humoral and cellular immunity following vaccination
National Institutes of Health
Grant: 5U01AI131566-04
Determining how macrophages regulate immunity to Zika virus infection at the maternal-fetal interface
National Institutes of Health
Grant: 2R01AI147394-06
Host cellular network governing the development of post SARS-CoV-2 tissue sequelae
National Institutes of Health
Grant: 1RF1NS122174-01
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy
National Institutes of Health
Grant: 1R01AG069264-01
Elucidating the roles of alveolar macrophage inflammation and selfrenewal during influenza infection
National Institutes of Health
Grant: 5R01NS103212-03
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions
National Institutes of Health
Grant: 5R01AI057459-16
Allergic inflammation and Transcriptional Regulation in Th9 cells
FWCI
15.15
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 10 of Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Additional file 10 of Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Additional file 11 of Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Additional file 11 of Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Additional file 1 of Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Additional file 1 of Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Additional file 2 of Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Additional file 2 of Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Additional file 3 of Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Additional file 3 of Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Additional file 1 of Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial
Additional file 1 of Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial
Additional file 2 of Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial
Additional file 2 of Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial
Additional file 1 of Long COVID symptoms after 8-month recovery: persistent static lung hyperinflation associated with small airway dysfunction
Additional file 1 of Long COVID symptoms after 8-month recovery: persistent static lung hyperinflation associated with small airway dysfunction